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Abstract
Background: The success of early reproductive events depends on an appropriate communication between
gametes/embryos and the oviduct. Extracellular vesicles (EVs) contained in oviductal secretions have been
suggested as new players in mediating this crucial cross-talk by transferring their cargo (proteins, mRNA and small
ncRNA) from cell to cell. However, little is known about the oviductal EVs (oEVS) composition and their implications
in the reproductive success. The aim of the study was to determine the oEVs content at protein, mRNA and small
RNA level and to examine whether the oEVs content is under the hormonal influence of the estrous cycle.
Results: We identified the presence of oEVs, exosomes and microvesicles, in the bovine oviductal fluid at different
stages of the estrous cycle (postovulatory-stage, early luteal phase, late luteal phase and pre-ovulatory stage) and
demonstrated that their composition is under hormonal regulation. RNA-sequencing identified 903 differentially
expressed transcripts (FDR < 0.001) in oEVs across the estrous cycle. Moreover, small RNA-Seq identified the
presence of different types of ncRNAs (miRNAs, rRNA fragments, tRNA fragments, snRNA, snoRNA, and other
ncRNAs), which were partially also under hormonal influence. Major differences were found between post-ovulatory
and the rest of the stages analyzed for mRNAs. Interesting miRNAs identified in oEVs and showing differential
abundance among stages, miR-34c and miR-449a, have been associated with defective cilia in the oviduct and
infertility. Furthermore, functional annotation of the differentially abundant mRNAs identified functions related to
exosome/vesicles, cilia expression, embryo development and many transcripts encoding ribosomal proteins.
Moreover, the analysis of oEVs protein content also revealed changes across the estrous cycle. Mass spectrometry
identified 336 clusters of proteins in oEVs, of which 170 were differentially abundant across the estrous cycle
(p-value< 0.05, ratio < 0.5 or ratio > 2). Our data revealed proteins related to early embryo development and
gamete-oviduct interactions as well as numerous ribosomal proteins.
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Conclusions: Our study provides with the first molecular signature of oEVs across the bovine estrous cycle,
revealing marked differences between post- and pre-ovulatory stages. Our findings contribute to a better
understanding of the potential role of oEVs as modulators of gamete/embryo-maternal interactions and their
implications for the reproductive success.
Keywords: Exosomes, Microvesicles, Oviduct, Hormones, Gamete/embryo-maternal interaction, Proteomics,
RNA-sequencing
Background
Exosomes and microvesicles, collectively called extracellu-
lar vesicles (EVs) are membrane-enclosed particles loaded
with a selection of proteins, lipids, and genetic materials
such as DNA, messenger RNA (mRNA), and small
non-coding RNA. By transferring this special cargo from
one cell to another, EVs play an important role in
cell-to-cell communication [1] exerting direct or indirect
effects into the recipient cells [2]. EVs have been isolated
from most cell types and biological fluids such as urine,
saliva, nasal and bronchial lavage fluid, breast milk, plasma
and serum [3] and also, in reproductive fluids (seminal,
follicular, uterine, oviductal fluids) [4–7]. EVs from the
oviductal fluid (oEVS), also known as oviductosomes, have
gained considerable attention in the recent years since
they might act as natural nanoshuttles, bringing key com-
ponents from the oviduct into gametes/embryos and
could play important roles in sperm capacitation,
fertilization and early embryo development [7, 9].
Thus, unraveling the molecular content of the oEVS
seems an important requisite to understand the possible
roles of the EVs in the gamete/embryo-oviduct dialog
and their implications in the reproductive success. To
the best of our knowledge, only the oEVs protein con-
tent have been examined to date. Two proteins, plasma
membrane calcium-transporting ATPase 4 (PMCA4)
and Sperm Adhesion Molecule 1 (SPAM1), associated to
essential steps before fertilization have been identified in
oviductosomes [7, 10]. Besides, our laboratory identified
319 proteins in bovine oEVs collected after ovulation
and revealed a group of proteins involved in
sperm-oocyte binding, fertilization and embryo develop-
ment [9]. Furthermore, we demonstrated that the
co-incubation of oEVs with in vitro produced embryos
increased blastocyst rates, extended embryo survival
over time and improved embryo quality [9], proving the
functional impact of these vesicles in supporting embryo
development. In the light of these results, our efforts in
this study have been directed towards a deeper
characterization of the oEVs cargo at mRNA, protein,
and small RNA level. Since proteins contained in oEVs
could have a direct impact on gametes/embryos after the
uptake [11] while RNA and small ncRNAs might have
an indirect effect by leading to the generation of
functional proteins or regulating the sperm/embryo
transcriptome, phenotype [12, 13] and their fate.
On the other hand, it is extensively known that steroid
hormones induce significant changes in the oviductal
transcriptome [14, 15] and in the oviductal fluid compos-
ition across the estrous cycle [16, 17]. These changes are
essential to provide the optimal environment for sperm
storage, capacitation, gamete transport, fertilization and
early embryo development [18]. Thus, it is very likely that
the oEVs’ composition might also be under regulation of
ovarian hormones, however, the impact of these changing
regulatory environment on the oEVs secretion and com-
position is still unknown. Recently, Greening et al., dem-
onstrated that the protein content of uterine EVs released
by human endometrial epithelial cells during in vitro cul-
ture was altered by estrogen and progesterone treatment,
suggesting hormone-specific changes of EVs cargo [19].
Therefore, the objective of the present study was to deter-
mine the hormonal regulatory effect of the estrous cycle on
the bovine oEVs content at the protein, messenger RNA
(mRNA) and small ncRNA level. Deciphering the oviduct
EVs content across the estrous cycle will reveal the poten-
tial role of these vesicles during the gamete/embryo-oviduc-
tal dialogue and their contribution during different stages
of the estrous cycle to the early reproductive success. More-
over, the knowledge derived from our study will open up
new possibilities for novel, exosome/microvesicles-based
treatments of pregnancy failure and infertility.
Results
Characterization and quantification of oviduct EVs across
the bovine estrous cycle
To obtain a biophysical and molecular characterization of
EVs in the oviduct fluid across the estrous cycle, TEM and
Western blot analysis were used, respectively. TEM obser-
vations confirmed the presence of EVs in bovine oviduct
flushings at the 4 stages of the cycle analyzed (Fig. 1a). All
preparations from 3 replicates at each stage of the cycle
analyzed showed a population of small extracellular vesi-
cles (30-100 nm) resembling exosomes and a population
of large extracellular vesicles (> 100 nm) resembling
microvesicles. In the literature, microvesicles range from
(> 100 up to ∼1000 nm) [20]. Histograms of Fig. 1 (b) show
the distribution of exosomes and microvesicles across the
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estrous cycle. The percentage of exosomes was significantly
higher than microvesicles (p < 0.05 for Stage 1 and 2, and p
< 0.01 for Stage 3 and 4) at all stages analyzed.
Western blotting for exosomal protein markers were
performed in EVs preparations across the estrous cycle.
EVs pool samples from all 4 stages were positive for
HSP70, a recognized exosomal protein (positive control)
present in 89% of exosome proteomic studies [21, 22] and
ANXA1 (Fig. 1c).
In addition, the size and concentration of bovine ovi-
duct EVs was measured by Nanosight nanoparticle
tracking analysis from a different batch of 12 samples (3
replicates/stage). Figure 1 (D) shows the size average and
concentration for each stage analyzed by Nanosight. No
significant differences were observed among stages re-
garding the size and concentration of EVs.
Changes in the oviduct EVs molecular content across the
bovine estrous cycle
Differential mRNA content of oviductal EVs across the
estrous cycle
Transcripts derived from a total number of 13,197 genes
were identified in the EVs for the analyzed stages of the
estrous cycle (after filtering for a minimum number of
read counts, see Methods section) (Additional file 1:
Table S0). The distribution of the normalized read
counts across all transcripts showed that most of the
transcripts occurred in low copy numbers and only the
top 500 most abundant transcripts/genes showed a fre-
quency of more than 25 transcripts per million.
(Additional file 2: Figure S1).
Multidimensional scaling plots (principal component
analysis) of normalized read count data revealed a clear
separation of the mRNA profiles of stage 1 (S1) EVs to
the other stages analyzed (Fig. 2a). Based on this finding,
a statistical analysis in comparison of the stages S2, S3,
and S4 to S1 was performed. The total number of differ-
ential transcripts (FDR 0.001) for these comparisons was
854 (Additional file 1: Table S4). The overlap of differen-
tial transcripts between the comparisons is shown in the
Venn diagram (Fig. 2b). Hierarchical cluster analysis of
the differential transcripts confirmed that the main dif-
ference in mRNA abundance was between S1 and the
other stages and that transcript frequency between S2,
S3, S4 was more or less similar (Fig. 2c; Additional file 1:
Tables S1-S3 and Additional file 2: Figure S2.). About
Fig. 1 Oviduct EVs characterization and quantification across the bovine estrous cycle. a Representative images of exosomes (blue arrows, 30–100 nm
size) and microvesicles (red arrows > 100 nm size) across the different stages of the bovine estrous cycle (Stage 1, Stage 2, Stage 3 and Stage 4) by
TEM. b Histograms showing the size distribution of oEVs across the estrous cycle. A batch of 12 samples containing 3 replicates/stage were analyzed
using TEM and ImageJ software. Comparison between populations of exosomes and microvesicles for each stage were performed (*P < 0.05; **P <
0.01, T-test. c Western blotting characterization of bovine oEVs at all 4 stages analyzed for known exosomal protein markers. A pool of samples
containing 3 biological replicates at the 4 different stages analyzed was used, showing oEVs from all 4 stages were positive for HSP70 and ANAX1.).
d Bovine oEVs size average and concentration was measured by Nanosight analysis from a different batch of 12 samples (3 replicates /stage)
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350 transcripts were more abundant in S1 EVs, while 500
showed increased frequencies in EVs from the other stages.
Functional analysis of the top 500 most abundant
mRNAs identified in EVs across the bovine estrous cycle
was performed using DAVID functional annotation clus-
tering (list of 500 most abundant transcripts in
Additional file 1: Table S5). A complete list of the GO
terms with a score ≥ 1.3 for the 500 most abundant
mRNAs are provided in Additional file 3 (Table S0). The
most descriptive categories grouped by similar GO terms
are shown in Table 1. The GO terms with highest en-
richment scores were associated to protein translation
and transport (63), extracellular vesicles (59.4), gene ex-
pression (46.5) and cell adhesion (40.5). Other interest-
ing GO terms were related to mitochondrion/
oxidation-reduction, apoptosis, response to stress and
immune response. A high number of transcripts of the
top 500 was associated with GO categories “response to
steroid hormones” and “growth factors”. While several
transcripts were related to “developmental process in
reproduction”.
To obtain a more meaningful view of the mRNA EVs
content in S1, GO terms of the 500 downregulated tran-
scripts and 354 upregulated transcripts were mapped in
a functional annotation network (Fig. 3). A list of the
categories shown in the network and assigned genes/
transcripts can be found in Additional file 3 (Table S1).
Enriched GO terms for upregulated transcripts were re-
lated to vesicles and exosomes such as: “extracellular
exosome” (number of transcripts: 74), “extracellular
vesicle” (74), “membrane-bounded vesicle” (96), “cyto-
plasmic vesicle” (36), and “membrane vesicles” (17).
Fig. 2 Comparative analysis of the oviduct EVs mRNA content across the bovine estrous cycle. a Principal Component analysis (PCA) on mRNA
oviduct EVs content at 4 different stages of the estrous cycle (S1 in yellow; S2 in red, S3 in green and S4 in blue). b Venn Diagram demonstrating
relations among differential transcripts (DT) for selected comparisons during the estrous cycle. Data were analyzed with a cut-off FDR < 0.001. c
Dendrogram representing results of unsupervised hierarchical clustering (HCL) created with Pearson correlation coefficient by MeV. Rows indicate
single differential transcripts (DT), while columns represent individual samples collected at different stages of the estrous cycle. Mean-centered
expression values (log2 counts per million of sample – mean of log2 counts per million of all samples) for the samples of the 4 stages are shown.
Color scale is from −4 (blue, lower than mean) to 4 (red, higher than mean)
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Upregulated transcripts were also involved in “endoplas-
mic reticulum” (43), “mitochondrial respiratory chain
complex assembly”, and “oxidative phosphorylation”
(11)., While downregulated transcripts were significantly
enriched in GO terms involved in embryo development
Table 1 DAVID functional annotation clusters for top 500 most
abundant mRNA identified in oEVs
Most descriptive categories of DAVID functional annotation
clusters groups by similar GO terms
#mRNA1 Score2
GO Group 1: Protein translation
and transport
236 63
protein transport (145, 2.8)3,
translation (129, 7.3), ribosome
(87, 11.4), protein targeting to
ER (81, 28.4), nuclear transport
(29, 2.2), regulation of protein
localization (40, 1.5)
GO Group 2: Extracellular vesicles 254 59.4
extracellular exosome (253, 3),
extracellular vesicle (253, 3),
phagocytosis (13, 1.7)
GO Group 3: Gene expression 314 46.5
RNA binding (203, 4.4), gene
expression (244, 1.7), negative
regulation of metabolic
process (109, 1.6), negative
regulation of transcription,
DNA-templated (42, 1.4)
GO Group 4: Cell adhesion 139 40.5
adherens junction (112, 5.3),
focal adhesion (77, 6.5),
cadherin binding (51, 5.9)
GO Group 5:
Mitochondrion/oxidation-reduction
131 7.4
mitochondrion (86, 1.7),
generation of precursor
metabolites and energy
(37, 3.6), oxidation-reduction
process (49, 1.8), ATP
metabolic process (30, 4.5),
oxidative phosphorylation (23, 4.2)
GO Group 6: Apoptosis 87 6
programmed cell death (87, 1.7),
apoptotic signaling pathway
(40, 2.5), apoptotic mitochondrial
changes (10, 3.1)
GO Group 7: ATPase/GTPase 54 6
nucleoside-triphosphatase
activity (51, 2.3), ATPase activity
(23, 1.9), GTPase activity
(21, 3.2), GTP binding (22, 2.0)
GO Group 8: Response to stress 172 5
cellular response to stress
(78, 1.6), response to oxidative
stress (28, 2.6), antioxidant
activity (11, 4.9), reactive
oxygen species metabolic
process (16, 2.6), regulation
of response to DNA
damage stimulus (10, 2.3)
GO Group 9: RNA processing/transport 42 3.3
RNA splicing (29, 2.6), mRNA
processing (25, 1.9), spliceosomal
complex (14, 2.6), RNA localization
(14, 2.4), nuclear export (10, 2.0)
GO Group 10: Immune response,
proteolysis
112 3.2
immune response (59, 1.4), regulation
of proteolysis (40, 2.1), regulation of
mRNA stability (23, 4.8), regulation
of cytokine production (26, 1.6),
platelet activation (13, 2.9),
Table 1 DAVID functional annotation clusters for top 500 most
abundant mRNA identified in oEVs (Continued)
Most descriptive categories of DAVID functional annotation
clusters groups by similar GO terms
#mRNA1 Score2
regulation of peptidase activity (23, 2.1)
GO Group 11: Cell cycle 64 2.9
mitotic cell cycle (45, 1.7), regulation
of cell cycle (40, 1.5)
GO Group 12: Cytoskeleton 71 2.7
cytoskeleton (50, 1.9),
microtubule (21, 1.7), cytoskeleton
organization (51, 1.6), actin
cytoskeleton organization
(28, 1.8), actin filament
organization (18, 2.0)
GO Group 13: Signal transduction,
phosphorylation
192 2.6
regulation of protein metabolic
process (118, 1.7), signal
transduction by protein
phosphorylation (38, 1.6),
intracellular signal transduction
(88, 1.2), phosphorylation
(75, 1.2), phosphorus
metabolic process (105, 1.2)
GO Group 14: Chromatin 23 2.6
chromatin DNA binding
(11, 3.8), protein-DNA complex
assembly (15, 2.3), chromatin
assembly (9, 2.0)
GO Group 15: Development 41 2.3
gland development (22, 1.9),
reproductive system development
(19, 1.6), developmental process
involved in reproduction (25, 1.4)
GO Group 16: Response to
hormones, growth factors, nutrients
80 2.2
response to organic cyclic
compound (42, 1.7), response to
steroid hormone (20, 1.9), response
to nutrient levels (19, 1.7), response
to growth factor (28, 1.6), response
to glucocorticoid (12, 3.1),
response to cAMP (8, 3.0)
GO Group 17: Cell organization 82 1.8
regulation of organelle organization
(47, 1.5), regulation of cellular
component organization
(76, 1.2), cell leading edge (20, 1.9)
GO Group 18: Others 68 2.6
energy reserve metabolic process
(11, 4.3), glycogen metabolic process
(10, 4.6), isomerase activity (13, 2.8),
muscle contraction (17, 1.9), organic
acid metabolic process (37, 1.5)
Table shows DAVID functional annotation clusters with a score ≥ 1.3. 1number
of unique mRNA in each GO group;2enrichment score (geometric mean of
member’s p-values of the corresponding annotation cluster in -log10 scale) of
the annotation cluster; 3in brackets: number of genes and fold enrichment for
the functional term
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such as: “chordate embryonic development”, “embryo
development ending in birth” or “egg hatching”, “in
utero embryonic development”, “morphogenesis of em-
bryonic epithelium”, and “embryonic epithelial tube for-
mation”. In addition, GO terms such as “cell
proliferation”, “cell cycle process”, “cell migration”, “cell
motility”, and epithelium and vasculature development
were obtained for downregulated transcripts. Moreover,
downregulated transcripts were significantly enriched for
terms related to regulation of gene expression, epigenetic,
regulation of histone modification and demethylation.
Differential protein content of oviductal EVs across the
estrous cycle
Unlike in our previous study where we analyzed the pro-
tein content of the oEVs at post-ovulatory stage [9], here
we analyzed the oEVs at different stages of the bovine
estrous cycle. Mass spectrometry analysis revealed differ-
ential protein abundance of EVs along the bovine estrous
cycle. Among the 336 identified clusters of proteins, 170
were differential among different stages of the estrous
cycle (p-value < 0.05, ratio < 0.5 or > 2). Complete lists of
identified and differentially abundant proteins are shown
in Additional file 1 (Tables S6-S8). A principal compo-
nent analysis of normalized weighted spectra data of the
top 200 proteins with highest differences across the
dataset revealed a clear separation of the protein profiles
for the 4 stages (Fig. 4A). Figure 4B represents a Venn
Diagram demonstrating the overlaps of differential pro-
teins for selected comparisons during the estrous cycle.
A higher number of differentially expressed proteins
(DEPs) was found between Stage 4 and Stage 1 (110)
than for the rest of the comparisons: S2 vs S1 (66) and
S3 and S1 (51). Twenty-five DEPs were overlapping be-
tween all comparisons. Hierarchical cluster analysis of
the DEPs shows the distinct protein expression profile of
EVs across the estrous cycle (Fig. 4C).
Functional annotation of all 336 clusters of proteins
identified in oEVs across the bovine estrous cycle was
performed using DAVID functional annotation cluster-
ing (Additional file 3: Table S2). Most descriptive cat-
egories of selected annotation clusters (enrichment
score ≥ 1.3) are shown in Table 2. The terms with the
highest number of proteins were related to “vesicle”,
“exosome”, “secretion”, and “endocytosis”. Other GO
terms with high enrichment scores were associated with
Fig. 3 Network of enriched GO terms associated to up and downregulated transcripts during stage 1 (S1). Comparative enrichment analysis of
GO terms associated to transcripts up or downregulated in oviduct EVs at stage 1 of the estrous cycle compared to the rest of the stages (S2, S3,
S4). The network shows enriched GO terms (biological process, a molecular function and cellular component) and pathways specifically
overrepresented for the up and downregulated transcripts
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cell adhesion/junction, protein targeting to ER/protein
folding, “regulation of secretion”, and “gene expression”.
“Protein biosynthesis”, “posttranscriptional regulation of
gene expression”, “regulation of protein modification
process” and “protein phosphorylation”, and “regulation
of cell communication” were also among the identified
overrepresented GO terms. A high number of proteins
in EVs were assigned to functional categories related to
proteolysis/cell cycle such as: “proteasome complex”,
“programmed cell death”, and “apoptosis”. Proteins
found in the EVs were also associated to “cell motility/
migration”, “response to oxidative stress”, “homeostatic
process”, and “epithelial cell differentiation” and “estab-
lishment or maintenance of cell polarity”. It is worthy to
mention the identification of a set of proteins (21) in
EVs related to zona pellucida receptor complex, binding
of sperm to zona pellucida and fertilization and steroid
binding proteins.
To illustrate overrepresented functional categories
with respect to changes in EVs proteins abundance
across the cycle, a network of shared GO terms of the
differential proteins is shown in Fig. 5. A list of the cat-
egories shown in the network and assigned genes/tran-
scripts can be found in Additional file 3 (Table S3). Five
clusters of proteins showing specific profiles across
stages were used for this purpose (clusters of proteins
are pointed with dotted squares: a, b-b’, c, d and e, in
Fig. 4C and listed in Additional file 3: Tables S4-S8). For
the cluster of proteins with lower abundance in stage 1
and upregulated in stage 4 (Fig. 4C, a) GO terms related
to vesicles, focal adhesion, cytoskeleton, cell surface,
metalloexopeptidase activity, and innate immune system
were found as overrepresented (Additional file 3: Table
S3). The cluster of proteins with highest concentrations
during stage 1 (Fig. 4C, b and b’) was enriched for terms
representing ribosome biogenesis and protein transla-
tion, protein folding, protein transport, protein process-
ing in endoplasmic reticulum, and focal adhesion.
Proteins upregulated in stage 2 and downregulated in
stage 4 (Fig. 4C, c) were also enriched for functional cat-
egories related to ribosome, protein translation and
transport, and focal adhesion. Furthermore, proteins of
A
B
C
a
d
b
c
e
b
Fig. 4 Comparative analysis of the oviduct EVs protein content across the bovine estrous cycle. A) Principal Component analysis (PCA) on protein
oviduct EVs content at 4 different stages of the estrus cycle (S1 in dark blue; S2 in light blue; S3 in brown and S4 in red) based on normalized
weighted spectra data. B) Venn Diagram demonstrating relations among differential proteins (DP) for selected comparisons during the estrous
cycle. Data were analyzed with cut-off FDR < 0.001. C) Dendrogram representing results of unsupervised hierarchical clustering (HCL) by MeV.
Mean-centered expression values (log2 expression value of sample – mean of log2 expression values of all samples) for the samples of the 4
stages are shown. Rows indicate single DP, while columns represent different stages of the estrous cycle. Clusters of proteins strongly
differentially regulated among stages are pointed with doted squares in HCL figure. These clusters of proteins were used for functional analysis
and GO enriched terms are shown in proteins network in Fig. 5
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this expression profile were involved in protein target-
ing, members of DNA helicase complexes, and the pro-
teasome complex. A small set of proteins showed
highest abundance in stage 3 (Fig. 4C, d). Specific
Table 2 DAVID functional annotation clusters for all proteins
identified in oEVs
Most descriptive categories of DAVID functional
annotation clusters groups by similar GO terms
#
Proteins1
Score2
GO Group 1: Vesicle/exosome/secretion 271 114.5
extracellular exosome (263, 4.2)3,
vesicle membrane (32, 2.8),
exocytosis (30, 3.9), secretion (50, 2.4)
GO Group 2: Cell adhesion/junction 141 49.9
adherens junction (106, 6.9),
cell-cell junction (61, 4.3)
cell-cell adhesion (71, 3.2),
cell junction organization (13, 2.7)
GO Group 3: Protein secretion/folding 129 29.1
protein targeting to ER
(42, 21.1), protein folding (27, 6.2),
Protein processing in endoplasmic
reticulum (15, 2.8),
regulation of secretion (23, 1.8)
GO Group 4: Gene expression 168 21.1
poly(A) RNA binding (102, 4.3),
gene expression (137, 1.4),
RNA biosynthetic process (87, 1.2)
GO Group 5: Wound
healing/coagulation
154 9.9
regulation of body fluid levels
(38, 4), coagulation (31, 4.5),
wound healing (37, 3.6),
platelet activation (21, 6.8),
blood circulation (19, 5.8)
GO Group 6: Small molecule binding 109 10.6
nucleoside-triphosphatase
activity (47, 3), small molecule
binding (96, 1.9), ATP binding
(57, 1.9), GTPase activity (22, 4.7)
GO Group 7: Signal transduction 137 7
posttranscriptional regulation
of gene expression (38, 4,2),
regulation of protein
modification process (62, 2),
protein phosphorylation
(59, 1.7), regulation of cell
communication (85, 1.5)
GO Group 8: Proteolysis/cell cycle 89 6
proteasome complex (14, 9.6),
mitotic cell cycle (37, 3.2),
proteolysis (57, 1.7),
endopeptidase activity (21, 2.1)
GO Group 9: Cytoskeleton
organization
95 5.4
cytoskeleton organization
(45, 2.1), microtubule
cytoskeleton (51, 2.1),
contractile fiber (15, 3),
actin filament organization
(19, 3), Ras GTPase binding (13, 2.4)
GO Group 10: Apoptosis 66 5.2
programmed cell death
(61, 1.7), intrinsic apoptotic
Table 2 DAVID functional annotation clusters for all proteins
identified in oEVs (Continued)
Most descriptive categories of DAVID functional
annotation clusters groups by similar GO terms
#
Proteins1
Score2
signaling pathway (12, 2.3), negative
regulation of intracellular
signal transduction (16, 1.8)
GO Group 11: Protein
stabilization/sperm-zona
pellucida interaction
21 4.9
protein stabilization (18, 6.9),
zona pellucida receptor complex
(6, 30.1), binding of sperm to
zona pellucida (7, 10.2),
fertilization (10, 3.2)
GO Group 12: Carbohydrate
derivative metabolism
60 3.8
carboxylic acid metabolic
process (35, 2.2), NADH
metabolic process (9, 12.7),
nucleotide metabolic process
(29, 2.3), carbohydrate
metabolic process (25, 1.7)
GO Group 13: Protein biosynthesis 19 3.7
Protein biosynthesis (16, 6.7),
tRNA aminoacylation (8, 7.9),
translational elongation (9, 3.5)
GO Group 14: Cell motility 52 3.4
locomotion (52, 1.8), cell
motility (47, 1.9), cell migration (42, 1.9)
GO Group 15: Oxidative stress 24 3.4
response to oxidative stress (20, 2.7),
reactive oxygen species
metabolic process (14, 3.3)
GO Group 16: Cell development 62 3.1
cell development (51, 1.4), epithelial
cell differentiation (20, 1.9), establishment
or maintenance of cell polarity (12, 3.7)
GO Group 17: Ion homeostasis 67 2.2
iron ion homeostasis (6, 4.4),
homeostatic process (56, 1.8),
ion homeostasis (22, 1.6),
regulation of ion transport (21, 2.0)
GO Group 18: Others 30 7.9
Annexin (9, 40.7), calcium-dependent
protein binding (13, 11.2),
phospholipid binding (19, 2.7),
high-density lipoprotein particle
(4, 6.9), steroid binding (6, 3.4)
Table shows DAVID functional annotation clusters with a score ≥ 1.3. 1number
of unique proteins in each GO group;2highest enrichment score (geometric
mean of member’s p-values of the corresponding annotation cluster in -log10
scale) of each group; 3in brackets: number of genes and fold enrichment for
the functional term
Almiñana et al. BMC Genomics  (2018) 19:622 Page 8 of 27
enrichment was only obtained for vesicle lumen proteins
involved in apoptotic signaling and in a scavenger recep-
tor pathway. Furthermore, proteins with lowest abun-
dance in stage 4 and highest in stage 3 were identified
(Fig. 4C, e). This group of proteins showed specific en-
richment for fructose/lipid/GDP binding, categories re-
lated to cytoskeleton organization and cell motility,
cytoplasmic vesicles, signal transduction, and secretory
processes (Additional file 3: Table S3).
Differential small ncRNA content of oviductal EVs across the
estrous cycle
The analysis of the small RNA content of oEVs revealed
in addition to miRNAs, sequences derived from various
classes of non-coding RNAs (ncRNAs). These ncRNAs
were ribosomal RNAs (5S, 5.8 S, 18S, 28S, and mito-
chondrial rRNA), tRNAs, small nucleolar RNAs (snoR-
NAs, e.g., SNORD, SNORA), small nuclear RNAs
(snRNAs, e.g., RN7SK, spliceosomal RNAs), and other
ncRNAs (7SL RNA, Y RNA, Vault RNA). Moreover, a
very low number of sequences for a few mRNAs was
identified (Additional file 1: Table S9). Some of these
mRNAs were highly abundant in the mRNA-Seq ana-
lysis. The sequences assigned to known or predicted
miRNAs comprised 189 different miRNAs based on se-
quence comparisons to known bovine, human, and por-
cine miRNAs, miRNA precursors, and predicted
precursor sequences (Additional file 1: Table S10).
RNA type distribution of the small RNA sequencing
data content across the estrous cycle showed that the
highest percentage of different sequence fragments cor-
responded to rRNAs (76%) followed by miRNAs (7%,
mainly various isoforms of mature miRNAs), unknown
sequences, tRNAs, other ncRNAs, snRNAs, snoRNAs,
and mRNAs (Fig. 6a). The percentage of read counts at-
tributed to each RNA type per stage of the cycle is
shown in Fig. 6b. With respect to read counts, the
highest percentage was also found for rRNA fragments
(61–71%), miRNAs (11.3–18.3%), and tRNA fragments
(9.2–12.4%). The variation between individual samples is
represented in Fig. 6c, showing the percentage of reads
attributed to each RNA type for each sample.
Comparative analysis of all small ncRNA content in-
cluding rRNA and tRNA fragments and for each individ-
ual RNA type across the bovine estrous cycle is
represented by several MDS plots in Additional file 2:
(Figure S3). In contrast to mRNA and protein EVs con-
tent, small ncRNA content did not shown a clear separ-
ation for the cycle stages based on all small ncRNA
types or the individual RNA types analyzed (rRNA,
tRNA, snoRNA, miRNA and other ncRNA). Only for
snRNA (Fig. 7), a partial grouping of stage 1 and 2 (S1,
S2) and stage 3 and 4 (S3, S4) samples was observed.
When all small ncRNA sequences were analyzed,
higher differences were found between stage 4 and stage
1 than between stage 3 and stage 1, with 1036 and 535
differentially abundant sequences (FDR < 0.05),
Fig. 5 Network of enriched GO terms associated to up and downregulated proteins during stage 1–4. Comparative enrichment analysis of GO terms
associated to clusters of differential proteins up or downregulated in oviduct EVs at 1–4 stages of the estrus cycle. The network shows the enriched GO
terms (biological process, a molecular function and cellular component) and pathways specifically overrepresented for the different protein cluster lists
showing differential expression across the estrous cycle. The 5 clusters of differential proteins used for building the network are represented in Fig. 4C
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respectively (Additional file 2: Figure S4). While no sig-
nificant differences were observed for stage 2 compared
to stage 1 for any of the individual ncRNA types ana-
lyzed. For rRNA fragments, 580 differential sequences
were found between stage 4 and stage 1 and 318 be-
tween stage 3 and stage 1 FDR (< 0.05) (Additional file
2: Figure S5). For miRNA, Table 3 shows differential
miRNAs among stages with 8 differentially regulated
miRNAs (20 sequences) between S4 vs S1, while 5 miR-
NAs (8 sequences) between S3 vs S1 (FDR < 0.05; Add-
itional file 2: Figure S6) (13 differentially regulated
miRNAs (39 sequences) S4 vs S1; 9 miRNAs (21 se-
quences) S3 vs S1; FDR < 1). Only for differential tRNA
(Additional file 2: Figure S7) and snRNA (Additional file
2: Figure S8), higher differences were observed between
stage 3 and stage 1 than for the comparison of stage 4
and stage 1 (tRNA: 29 (S3 vs S1) and 6 (S4 vs S1);
snRNA: 93 (S3 vs S1) and 85 (S4 vs S1), FDR (< 0.05)).
Hierarchical cluster analyses of the differential sequences
identified for each type of small ncRNA between stage
3–4 and stage 1 are provided in Additional file 2: Figures
S4-S9. However, the biological function of differentially
abundant rRNA and tRNA fragments is questionable.
In order to shed some light on the potential impact of
EVs’ miRNAs on spermatozoa or early embryos, func-
tional and gene target analyses were performed on 13 se-
lected miRNAs showing differential expression (FDR 0.1)
among stages and high abundance in EVs during Stage 1
Fig. 6 RNA type distribution of the oviduct EVs small ncRNA content across the bovine estrous cycle. a Pie graph shows the percentage of
sequences attributed to each RNA type among all ncRNAs identified by small RNA sequencing in oviduct EVs across the cycle (miRNAs, rRNA
fragments, tRNA fragments, snRNA, snoRNA, and other ncRNAs). b Bar graph shows the percent of reads attributed to each RNA type per stage
of cycle. c Bar graph shows the percent of reads attributed to each RNA type for each sample
Fig. 7 Comparative analysis of the snRNA expression across the
bovine estrous cycle. Principal Component analysis (PCA) on snRNA
oviduct EVs content at 4 different stages of the estrous cycle (Stage
1: S1 in yellow; Stage 2: S2 in red, Stage 3: S3 in green and Stage 4:
S4 in blue) for all snRNA identified. Five different replicates for each
stage were analysed (represented by R1, R2, R3, R4 and R5) in the
plot. PCA showed a partial separation between stage 1 and 2 (S1,
S2) and stages 3 and 4 (S3, S4)
Table 3 List of differential miRNAs among S3 vs S1 and S4 vs
S1 (FDR < 0.1)
Stage
comparison
Regulation
UP DOWN
S3 vs S1 bta-miR-10b bta-miR-449a
bta-miR-125b-2-5p bta-miR-200b-3p
bta-miR-92a hsa-miR-203a-3p
bta-miR-423-3p bta-miR-375
bta-miR-429
S4 vs S1 bta-miR-10b bta-miR-200b-3p
bta-miR-151-3p bta-miR-449a
bta-miR-24-3p Novel miRNA
bta-miR-28-5p bta-miR-34b-3p
bta-miR-29c
bta-miR-423-3p
bta-miR-30d
bta-miR-148a-3p
bta-miR-125b-2-5p
All miRNA FDR < 0.1; miRNA FDR < 0.05 in bold
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Table 4 Selected miRNAs in oEVs in Stage 1 and 4 and associated pathways and target genes
miRNAs KEGG pathway p-
value
Examples Target Genes (Gene Symbol)
hsa-mir-
10b-5p
Pyrimidine metabolism 0.0214 NME4,NME2,POLR2D,POLR2A,POLR1B,NME1,CMPK1
hsa-miR-
423-3p
Fatty acid biosynthesis 0.0000 FASN, ACACA
Fatty acid metabolism 0.0000 FASN, ACACA, ACOX3, FADS2
hsa-miR-
449a
Carbon metabolism 0.0286 TKT,GAPDH,GOT1,H6PD,MDH2,RPIA,ENO1,ALDOA,ADH5
HIF-1 signaling pathway 0.0390 NFKB1,GAPDH,LTBR,BCL2,ENO1,LDHA,PIK3CA,SLC2A1,MKNK2,ALDOA,SERPINE1
hsa-miR-375 Hippo signaling pathway 0.0000 YAP1,YWHAG,CCND2,MOB1B,YWHAB,WWC1,AMOT,FZD8,MPP5,FZD4,DLG4,
Amino sugar and nucleotide sugar
metabolism
0.0390 PGM2,CMAS,UXS1,UGP2,HK2
hsa-miR-24-
3p
Fatty acid biosynthesis 0.0000 FASN,MCAT,ACACA
Vitamin B6 metabolism 0.0001 PDXK,PNPO,PHOSPHO2
Endocytosis 0.0005 RNF41,PSD4,CHMP7,VPS45,SMAD2,CBL,DNM2,FGFR3,VTA1,AGAP3,CAV1,AP2B1,N
Hippo signaling pathway 0.0014 ACTB,GSK3B,FZD5,YWHAH,SMAD2,BTRC,APC,NF2,YWHAG,SMAD3,WWTR1,TGFB1,
Bacterial invasion of epithelial cells 0.0078 ACTB,ITGB1,CBL,DNM2,PIK3CB,CAV1,PXN,BCAR1,CLTC,CD2AP,CAV2,CTTN,PTK2,
TGF-beta signaling pathway 0.0228 SMAD2,ACVR1B,SMAD3,TGFB1,SKP1,MYC,EP300,IFNG,E2F4,CREBBP,TGFBR2,BMP4,
Glycosaminoglycan biosynthesis - heparan
sulfate / heparin
0.0343 HS6ST2,NDST1,HS6ST1,EXTL3,HS2ST1,HS6ST3
DNA replication 0.0343 CNA,FEN1,MCM4,MCM5,MCM7,RNASEH1,PRIM1,POLA1
RNA degradation 0.0423 PDCP1A,CNOT6,TOB2,CNOT4,DDX6,HSPD1,EXOSC3,EXOSC1,BTG2,DCP2,RQCD1,
hsa-miR-429 Axon guidance 0.0009 PAK2,PPP3R1,RHOA,KRAS,PPP3CA,PTK2,CFL2,RAC1,LIMK1,EFNA1
Fc gamma R-mediated phagocytosis 0.0350 CRKL,CRK,WASF3,PLCG1,CFL2,RAC1,LIMK1,ARF6
Steroid biosynthesis 0.0000 SC5D,MSMO1,DHCR24,LSS,FDFT1,LIPA
Antigen processing and presentation 0.0019 B2M,IFI30,HSPA4,HSP90AA1,HLA-C,HLA-B,NFYA,PSME2,CANX,PDIA3,HSPA8,
Progesterone-mediated oocyte maturation 0.0039 ADCY1,CCNB1,PGR,ADCY7,CCNA2,CDC25B,CPEB4,HSP90AA1,PDE3A,RAF1,
Gap junction 0.0346 ADCY1,ADCY7,GNAS,MAP2K5,RAF1,TUBB,TUBB6,CDK1,KRAS,TUBA8,GNA11
hsa-miR-
34b-3p
Glycosaminoglycan degradation 0.0000 GNS,IDS,GLB1
hsa-miR-
200b-3p
Ras signaling pathway 0.0043 KSR1,RASA2,SHC1,PAK2,ETS1,RALBP1,PLD1,RHOA,KRAS,PLCG1,REL,FLT1,
Neurotrophin signaling pathway 0.0273 CRKL,CRK,SHC1,FRS2,BCL2,RHOA,KRAS,RPS6KA5,PLCG1,JUN,KIDINS220
hsa-miR-
92a-3p
Cell cycle 0.0000 GSK3B,PCNA,SMC1A,CCNB1,SMAD2,HDAC1,CCND2,DBF4,SMC3,CDKN1B,
Adherens junction 0.0000 ACTB,TGFBR1,WASL,SMAD2,IQGAP1,IGF1R,VCL,FYN,MLLT4,NLK,CDH1,S
Thyroid hormone signaling pathway 0.0011 ACTB,GSK3B,PRKCA,MED13L,NRAS,RCAN1,PIK3CB,HDAC1,MED13,NOTCH2
FoxO signaling pathway 0.0024 IRS2,BRAF,STAT3,TGFBR1,CCNB1,SMAD2,NRAS,STK4,GABARAPL2,PIK3CB,SETD7
RNA transport 0.0025 SAP18,GEMIN6,NUP153,TGS1,NUP210,XPOT,EIF3B,ELAC2,RPP14,EIF2S3,RNPS1
p53 signaling pathway 0.0045 CCNB1,BID,THBS1,CCND2,CDK1,GADD45A,CDK6,CHEK1,ATM,CCND1,CCNE2,SHISA5
Signaling pathways regulating pluripotency
of stem cells
0.0178 PCGF6,JARID2,TCF3,GSK3B,STAT3,KAT6A,SMAD2,NRAS,INHBB,PIK3CB,WNT5A,TBX3
Protein processing in endoplasmic
reticulum
0.0179 HSPA1A,EIF2AK1,RAD23B,ERO1L,NPLOC4,SEL1L,UBQLN1,SEC23A,SSR2,P4HB,XBP1
Notch signaling pathway 0.0190 HDAC1,CTBP1,DTX2,NOTCH2,HES1,HDAC2,KAT2A,RBPJ,KAT2B,EP300,CREBBP,MAML1
Spliceosome 0.0210 HSPA1A,LSM7,DDX23,SRSF5,PPIL1,U2SURP,EFTUD2,SF3B1,U2AF2,SNRPE,SF3A3
MAPK signaling pathway 0.0210 BRAF,DUSP4,PRKCA,HSPA1A,TGFBR1,NFKB1,NRAS,CRKL,STK4,ELK4,CRK,DUSP6
Wnt signaling pathway 0.0386 GSK3B,PRKCA,LRP6,TBL1X,BTRC,VANGL1,WNT5A,CTBP1,CCND2,FZD6,AXIN1,SKP1
Focal adhesion 0.0393 BRAF,ACTB,GSK3B,PRKCA,ITGB8,CRKL,CRK,THBS1,ITGA8,PIK3CB,PIP5K1C,PPP1CC
Biosynthesis of amino acids 0.0473 TKT,BCAT2,GAPDH,PHGDH,TALDO1,PKM,SHMT2,BCAT1,MTR,ENO1,GOT2,PFKM,ASS1
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Table 4 Selected miRNAs in oEVs in Stage 1 and 4 and associated pathways and target genes (Continued)
miRNAs KEGG pathway p-
value
Examples Target Genes (Gene Symbol)
hsa-miR-
151a-3p
Biosynthesis of unsaturated fatty acids 0.0000 PTPLB,ELOVL5,SCD
Fatty acid metabolism 0.0003 HADH, PTPLB,ACACA,SCD,ELOVL5
hsa-miR-
30d-5p
Mucin type O-Glycan biosynthesis 0.0000 GALNT7,B4GALT5,ST3GAL1,GALNT6,GCNT3,GALNT1,GALNT3,GALNT2
Oocyte meiosis 0.0000 FBXO5,CAMK2D,PGR,BTRC,CALM1,CPEB4,YWHAG,PPP1CC,PPP3R1
Ubiquitin mediated proteolysis 0.0000 UBE2R2,BTRC,FBXW7,TRIM37,CUL2,NEDD4L,FZR1,PRPF19,MAP3K1
mRNA surveillance pathway 0.0317 MSI2,SAP18,PPP2R3A,EIF4A3,HBS1L,PPP1CC,CPSF2,CPSF6,PAPOLA
hsa-miR-
125b-5p
ErbB signaling pathway 0.0016 PRKCA,ERBB2,NRAS,CRKL,CRK,PAK2,RAF1,CDKN1B,EIF4EBP1,ERBB3
Regulation of actin cytoskeleton 0.0135 SSH2,EZR,NRAS,CRKL,CRK,PIP5K1C,PAK2,ARHGEF12,PPP1CC,ACTG1
Table shows selected miRNAs based on differential expression and high abundance in EVs in Stage 1 and Stage 4 and associated representative pathways and
target genes
Fig. 8 Selected miRNA and their associated pathways. Selected miRNAs based on differential expression and high abundance in EVs in Stage 1
and Stage 4 were used for clustering analysis based on the presence of interactions of target genes and pathways using DIANA-miRPath v3.0.
Heatmap clustering of 13 miRNAs versus their associated pathways based on significance levels. Color scale from red (highest significance) to
yellow (not significant)
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and Stage 4 (hsa-mir-10b-5p, hsa-miR-423-3p;
hsa-miR-449, hsa-miR-375, hsa-miR-24-3p, hsa-miR-429,
hsa-miR-148a-3p, hsa-miR-34b-3p, hsa-miR-200b-3p,
hsa-miR-92a-3p, hsa-miR-151a-3p, hsa-miR-30d-5p,
hsa-miR-125b-5p). For this purpose, human orthologous
miRNAs were used for analysis in the DIANA-TarBase v7
tool. The selected miRNAs, pathways involved and the
number of genes and gene symbols of the target genes in
each pathway are shown in Table 4 and Additional file 3
(Table S9–10). This data was used for cluster analysis
based on presence of interactions of target genes and
pathways by DIANA-miRPath v3.0. The depicted
heatmap shows the 13 selected miRNAs versus
pathways based on significance levels (Fig. 8). Inter-
esting pathways targeted by these 13 miRNAs were
fatty acid biosynthesis and metabolism; mucin type
O-Glycan biosynthesis, cell cycle, focal adhesion,
adherens junction, gap junction, thyroid hormone
signaling pathway, HIF-1 signaling pathway, p53 sig-
naling pathway, FoxO signaling pathway, TGF-beta
signaling pathway, Ras signaling pathway, Wnt sig-
naling pathway, and protein processing in endoplas-
mic reticulum. Pathways related to reproductive
functions were also identified: steroid biosynthesis,
progesterone-mediated oocyte maturation and oocyte
meiosis.
A
C
B
Fig. 9 Validation of Mass Spectrometry and miRNA analyses of bovine oEVs by Western immunoblotting and qPCR. a Western blot analysis
confirmed MS results for 3 proteins associated with reproductive roles and showing differential abundance or not across the bovine estrus cycle:
CD109, HSPA8 and MYH9. A pool of samples containing 3 biological replicates at the 4 different stages analyzed was used. b qPCR analysis
confirmed miRNA-seq results for Mir-449a, which dysregulation has been associated with defective cilia in the oviduct and infertility. Mir-449a was
more abundant in S1 compared to the rest of the stages (p < 0.05, T-test). A new batch of oEVs isolated from oviducts classified in the four stages
of the estrous cycle (n = 12) was used. c Network of Mir-449a target genes and overrepresented functional categories
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Validation of interesting proteins and miRNA identified in
oviductal EVs by western blotting and qPCR
Proteomic results were confirmed by Western blot ana-
lysis for three of the top 25 proteins most abundant in
proteins in oEVs and associated to reproductive functions
(CD109, HSPA8 and myosin 9; Fig. 9a). CD109 was not
found as differentially regulated across the estrous cycle.
HSPA8 was more abundant at S1 compared to the rest of
the stages (S2, S3 and S4). By contrast MYH9 was less
abundant in S1 than in the stages S2, S3 and S4. These re-
sults confirmed the different proteomic profile of oEVs at
different stages of the bovine estrous cycle.
The differential regulation of mir-449a in oEVs across
estrous cycle detected by RNA-seq analysis was also con-
firmed by qPCR in a different set of samples (Fig. 9b).
Dysregulation of mir-449a has been associated with de-
fective cilia in the oviduct and infertility. Mir-449a was
more abundant in S1 compared to the rest of the stages,
which may downregulate a set of target genes in S1 in
contrast to the other stages of the cycle. To investigate the
possible target genes for mir-449a, DIANA tool was used
with two different databases (TarBase and TargetScan).
TarBase showed 512 target genes for mir-449a, while Tar-
getScan showed 283 genes. Comparative analysis of these
two lists of target genes for mir-449a provided 32 com-
mon target genes that were used for further functional
analysis using ToppCluster tool. Network in Fig. 9c shows
the target genes (in red) for mir-449a and the network for
GO enriched terms for those target genes. Furthermore,
GO terms associated to embryo development, embryonic
morphogenesis and stem cell division were identified. Fur-
thermore, target genes were involved in, wound healing,
angiogenesis and vasculature development. Besides, genes
related to homeostasis, response to oxidative stress and
chemotaxis or cell motility were also found. In addition,
target genes were involved in cell cycle, focal adhesion and
Notch signaling pathways among other.
Discussion
This study demonstrates that oviductal epithelial cells
can release EVs (exosomes and microvesicles) to the ovi-
ductal environment at different stages of the estrous
cycle and that their molecular cargo is markedly regu-
lated by steroid hormones. So far, only a few studies
have investigated the effects of oEVs on murine sperm
functionality and early bovine embryo development in
vitro [7, 9, 23, 24]. While a systematic analysis of the
oEVs content at mRNA, small ncRNA and protein levels
to help to understand the effects of oEVs on spermato-
zoa and embryo was lacking. We did a first approach in
our lab by comparing the protein content of in vivo
oEVs obtained at the post-ovulatory stage of the bovine
estrous cycle and in vitro oEVS obtained from in vitro
culture of BOEC and showing a differential protein
profile [9]. This study led us to hypothesize that the
oEVs content may be under hormonal regulation and
suggested to further investigate the oEVs cargo at differ-
ent levels. Here, we provide the first extensive analysis of
the molecular signature of oEVs at transcriptomic and
proteomic levels across the bovine estrous cycle.
Recently, Burns et al., [25] showed that the amount of
EVs in the ovine uterine lumen increased from day 10 to
14 of estrus cycle and also, after P4 treatment for
14 days, suggesting that P4 may regulate endometrial
epithelial production of EVs and their release into the
uterine lumen. To evaluate the oEVs concentration along
the estrus cycle in our study, two different methods (TEM
and Nanosight) with two different batches of samples were
used. However, the amount and size distribution of EVs in
the oviductal fluid did not vary among the different stages
of the estrous cycle (Fig. 1), despite the molecular cargo
was under strong hormonal regulation. Differences in spe-
cies (bovine versus ovine), source of EVs (oviduct versus
uterus), window of the cycle (short period 10–14
post-estrus versus 4 stages of the cycle), hormonal induc-
tion (natural versus artificial by injecting intramuscularly
same amount of P4 during 14 days) could explain the dif-
ferent findings among studies.
Protein cargo in oviductal EVs is under hormonal
regulation
Proteomic analysis showed differential protein profiles
across the different stages of the estrous cycle, demon-
strating a strong effect of the steroid hormones on oEVs
protein cargo. Of the 336 proteins identified in oEVs,
170 were differentially abundant across the estrous cycle
and could be grouped in different clusters of proteins
based on similar profiles over the cycle stages. Our data
are in line with recent studies showing a hormonal effect
on the protein cargo of exosomes/EVs derived from the
uterus. Greening et al., [19] showed that the exosome pro-
tein cargo derived from a human endometrial cell line was
also under hormonal regulation. In this case, the authors
treated endometrial cells with estrogen (E) or estrogen
plus progesterone (E + P) during culture to mimic the hor-
monal profile in the proliferative and secretory phases of
the menstrual cycle. They found 254 proteins as enriched
in exosomes produced by E-treated cells while 126 pro-
teins were enriched in exosomes from E + P-treated cells.
Moreover, Burns et al., [26] showed a differential protein
content in uterine EVs collected from day 14 cyclic sheep
(40 unique proteins) compared to pregnant sheep (70
unique proteins), demonstrating also a strong hormonal
regulation of the uterine EVs protein content. We com-
pared our list of oEVs proteins with those studies and
found that 171 proteins were in common to Greening et
al., [19], while only 16 were shared with Burns et al., [26].
It is worth pointing out that our study differs from
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Greening et al. [19] and Burns [25] in two important as-
pects: 1) the source of EVs, in our study is the oviduct
while the uterus in those studies, differences may point to
a specific oviductal EVs signature and 2) we showed a
more biological and natural effect, since our samples were
collected from cyclic animals and not induced artificially
by hormonal treatment in vivo or in vitro.
Among the oEVs proteins identified, we found an im-
portant number of proteins in common to other studies
[19], which include proteins involved in exosome biogen-
esis (ESCRT-associated: VPS13C, FAM129B, PDCD6IP)
and intracellular vesicle trafficking and release (DYN-
C1LI1; SNAP23, STXBP1). In addition, tetraspanins
(CD9) and GTPases (RAB1A, RAB2A, RAB7A, RAB11A,
RAB5C) were identified in oEVs. Several proteins involved
in exosome sorting (COPA, CLTC, ARF1, RAC1) were
also found. Furthermore, oEVs were enriched in Annexins,
another class of proteins commonly seen in exosomes, in-
volved in membrane trafficking and fusion events
(ANXA1–8, ANXA10). Oviductal EVs were also enriched
for heat-shock proteins (HSP90, HSC70) involved in
homeostasis and crucial functions in the biosynthesis,
folding/unfolding, transport and folding of proteins [27].
Despite we found a number of proteins characteristic
of the exosomal proteomic signature in different cells
types/tissues, we also identified proteins characteris-
tic of the oviduct with important roles in the
gamete/embryo–oviduct interactions, such OVGP1,
together with ANXA2, HSPA8, HSP90, HSP70, Gel-
solin and Ezrin, pointing out to an oviductal EVs sig-
nature. Particularly OVGP1, it has been identified as
one of the major expressed proteins in this organ.
Further comparison of our data with the protein cargo
of oviductosomes was difficult, since so far, no available
studies have provided an extensive analysis of the ovi-
ductosome content in addition to our own studies.
The available studies have focused only on the pro-
files of specific proteins such as: plasma membrane
Ca+ 2-ATPase 4 (PMCA4) [7] and sperm adhesion mol-
ecule 1 (SPAM1) [10]. PMCA4 is involved in regulating
progressive and hyperactivated sperm motility, while
SPAM1 seems to enhance hyaluronic acid-binding ability
and cumulus penetration efficiency, both essential steps
for fertilization [7, 10, 28, 29]. It has been shown that
A B
C D
Fig. 10 Overlap of all transcripts and proteins identified in oviduct EVs across the bovine estrus cycle. a Venn Diagram demonstrating the overlap
among all transcripts and proteins identified in EVs; b Heatmap representing results of unsupervised hierarchical clustering (HCL) by MeV. Rows
indicate single proteins and transcripts, while columns represent different stages of the estrous cycle for transcripts (TS1-TS4) and proteins (PS1-
PS4) analyses. Expression values for proteins and transcripts were log2-transformed and scaled to have values in a similar numerical range. c
Heatmap representing the 25 top most abundant proteins which were attributed to known exosomal proteins (Annexins, Heat Shock proteins)
and proteins associated to reproductive roles (OVGP, HSPA8). d Heatmap showing the 25 top most abundant transcripts representing mainly
mRNAs encoding different ribosomal proteins (RPS, RPL)
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PMCA4 is also under the control of female sex hormones,
showing elevated levels of the protein in oviductal and
uterine fluids in the mouse during proestrus/estrus com-
pared to metestrus/diestrus [7]. However, neither PMCA4
nor SPAM1 were identified in our study at protein or
mRNA level. This most likely relates to differences in the
methodology to isolate oEVs, the proteomic approach or
species-specific differences [30]. However, when we com-
pared the proteins identified here with our previous study
[9], where oEVs were only from post-ovulatory stage, we
found that 69% of proteins (184 proteins) were in com-
mon to both studies.
Furthermore, more differences in oEVs protein cargo
were identified between post-ovulatory (S1) and
pre-ovulatory (S4) stages (S4 vs S1: 110 proteins) com-
pared to luteal phase (S2 vs S1: 66 proteins and S3 vs
S1, 51 proteins). For example, MIF, AQP5, HSPA8, asso-
ciated to reproductive events [31, 32] were more abun-
dant in EVs of S1 than S4. Our results are in line with
other studies showing that the expression of these pro-
teins in oviductal epithelial cells and/or fluid was higher
during the post-ovulatory stage when compared to the
pre-ovulatory stage [16, 33, 34]. In contrast, MYH9 (my-
osin heavy chain 9) and CLTC (clathrin heavy chain)
proteins were more abundant in EVs during the
pre-ovulatory stage in our study. Similar results were
found also in the oviductal fluid in cattle and sheep
[16, 35]. The proteins identified with higher abun-
dance during the pre-ovulatory period, could play an
important role in maintaining sperm viability in the
“sperm reservoir” [36]. While the proteins with higher
abundance during the post-ovulatory period could be
involved in: final maturation of the oocyte and trans-
port to the fertilization place; release of spermato-
zoids from the sperm reservoir, sperm hyperactivation
and sperm transport toward the oocyte; interaction
sperm-oocyte and fertilization; and finally, the early
development of the embryo [37].
Indeed, among the 25 most abundant proteins in oEVs
(Fig. 10c), which could exert a major effect when they
are taken up by gametes/embryos, we identified 4 heat
shock proteins (HSPs): HSPB1, HSPA8, HSP90AA1,
HSPA1A. HSPs are among the first proteins produced
during embryonic development and are crucial in
fertilization and in early embryonic development [38].
Small heat shock protein 25 (HSPB1) plays an important
role by acting synergistically with other HSPs during
stress conditions to exert cryoprotection and
anti-apoptotic effects [39]. Other HSPs identified here
such as HSPA1A (HSP70), HSPA8 and HSP90AA1, to-
gether with OVGP1, gelsolin and ezrin, have important
roles in the sperm-oviduct interaction and early embryo
development, as we discussed in detail in our previous
study [9]. Annexins 1, 2, 4, 5 which have been proposed
as oviductal receptors for bovine sperm surface proteins
and thus, serving to hold bovine sperm in the oviductal
reservoir [40], were also found in oEVs. Clusterin (CLU)
was increased during the postovulatory stage. Clusterin
concentration in seminal plasma has been shown to cor-
relate with sperm parameters such as reduced DNA
fragmentation and sperm morphology [41] suggesting a
positive effect of EVs’ CLU on gametes and the early em-
bryo. Furthermore, CD109, which plays a role in avoid-
ing detection by the female reproductive tract immune
system [42], was found highly abundant in EVs and with
no differential variation among stages.
RNA cargo in oviductal EVs is under hormonal regulation
Total RNA isolated from oEVs with standard RNeasy
micro kit and with miRNeasy mini kit (enriches shorter
RNAs), respectively, were analyzed for size distribution
and quality using the Agilent Bioanalyzer. Results from
the RNA 6000 Pico chip for the RNeasy kit showed high
integrity of the isolated RNA for most of the samples, with
prominent 18S and 28S rRNA fragments (represented by
peaks around 2000 and 4000 nt). Results from the small
RNA assay (for miRNeasy) showed small RNA profiles in
the range of less than 20 to 200 nucleotides, that could
correspond to miRNAs (≈ 22 nt), tRNAs (≈ 60–90 nt),
(snoRNA (≈ 70–90 nt), vault RNA (≈ 80–110 nt), Y_RNA
(84–113 nt), snRNAs (≈ 63–190 nt), and small ribosomal
RNAs (5S and 5.8 S). Results from mRNA-seq and small
RNA-seq confirmed the presence of a high number of
mRNAs and also different types of small ncRNA in oEVs
as well as fragments of rRNAs and tRNAs, in line
with the EVs RNA cargo derived from other sources
[43, 44]. These studies showed that depending on the
type of vesicles, intact protein-coding transcripts are
present as well as ribosomal RNAs, and a variety of
other small and long ncRNAs.
Regarding the mRNA content, we would like to high-
light the presence of a high number of transcripts but in
low copy number in oEVs. Only the top 500 most abun-
dant transcripts showed a frequency of more than 25
transcripts per million. This arbitrary threshold was set
to select transcripts for further functional analysis since
we hypothesize that transcripts with lower concentra-
tions in EVs are not very likely to have an effect on
spermatozoa/embryo. Studies regarding the abundance
and length of mRNAs loaded into EVs are rare and
contradictory. Some studies found that EVs contained
mainly RNA fragments [45]. In contrast, a few studies
have demonstrated the presence of full-length and func-
tional mRNA in exosomes [1]. Based on the results from
the Bioanalyzer and the obtained mRNA-sequencing
data, we conclude that bovine oEVs isolated with the
protocol used in our study are containing full-length
mRNAs and ncRNAs. The profile of the total RNA
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looked similar to total RNA isolated from cells or tis-
sues. Furthermore, the analysis of exon coverage of the
RNA-seq data (Additional file 2: Figure S12, IGV Sash-
imi plots) suggested the presence of complete unde-
graded transcripts. In addition, this analysis for some
selected genes suggested the existence of splicing vari-
ants of mRNAs identified in oEVs.
Functional annotation revealed clusters of related
terms with highest enrichments scores for the 500 most
abundant transcripts in S1, were associated to protein
translation and transport, extracellular vesicles, gene ex-
pression, response to stress and immune response and
response to steroid hormones. We hypothesized that
these transcripts could be transferred to gametes/em-
bryos, in which they could be translated to functional
proteins and exert an effect.
Our data also showed that mRNAs encoding riboso-
mal proteins of the large (RPL) and small subunit (RPS),
are the most abundant protein-coding RNAs in oEVs,
which is in line with other studies [43, 46]. Among the
100 most abundant mRNAs, we found 74 encoding ribo-
somal proteins and five mRNAs for translation elong-
ation and initiation factors. Ribosomal proteins are
playing an essential role in protein translation, but as
well as, in tumorigenesis, immune signaling, and devel-
opment [47]. Following our hypothesis that EVs mRNAs
could be translated into proteins upon arrival to em-
bryos, these transcripts may support ribosomal functions
to ensure efficient translation of other EVs mRNAs
where the EVs cargo is released [48]. It could even be
possible that necessary components for protein transla-
tion are coming with the oEVs to the recipient cells
since they contain rRNAs, ribosomal proteins, transla-
tion factors, and tRNAs. Among the most frequent tran-
scripts were also mRNAs not involved in translation or
protein processing. For the most frequent mRNA, tumor
protein, translationally-controlled 1 (TPT1), has been
shown to activate pluripotency genes such as NANOG
and OCT4 in oocytes [49].
In a similar way to the oEVs protein content, a strong
difference in mRNA composition between S1 and the
other stages was found. We identified a high number of
differential transcripts (854) in oEVs between S1 vs S4.
Our results are in line with Burns et al. [25], identifying
an important number of differential transcripts (1611) in
uterine EVs collected under different hormonal stimulus.
Enriched GO terms for upregulated DET during S1 were
mainly related to “extracellular exosome”, “extracellular
vesicle”, and “oxidative phosphorylation”. While the
downregulated DET were involved in embryo develop-
ment, cell proliferation, epigenetic, regulation of histone
modification and demethylation. Particularly interesting
is the enrichment of functional categories related to epi-
genetic regulation of gene expression. These categories
contained many genes involved in chromatin modifica-
tion including histone methyltransferases (EHMT1,
EHMT2, EZH1, KMT2A, KMT2B, KMT2C, PHF1,
PHF2, PRMT5, SETD1A, SETD2) and histone demethy-
lases (ARID5B, JMJD1C, KDM2A, KDM3B, KDM5B,
KDM5C, KDM6B), but also one DNA methyltransferase
gene (DNMT1), which were expressed in EVs of all
stages but slightly lower in S1 EVs. This finding suggests
that chromatin modification in the early embryo could
be in part under maternal control via transcripts derived
from oEVs. Furthermore, since studies in bovine IVP
embryos showed distinct spatiotemporal expression pat-
terns of genes involved in chromatin modification, a po-
tential transfer of mRNAs of involved genes could be
another factor for differences between in vitro and in
vivo embryo development [50, 51] Considering how the
hormones regulate the EVs RNA cargo, we pose the
question whether the presence of spermatozoa and/or
embryos in the oviduct could modulate the oEVs com-
position. Further investigations evaluating the oviductal
response to sperm/embryo in terms of EVs release and
cargo will help to answer this question.
Results from small RNA-sequencing revealed that a
substantial proportion (76%) of reads aligned to rRNA in
oEVs. A similar small ncRNA exosomal profile was ob-
served in urinary EVs or EVs derived from human gli-
oma stem cells culture among others, where rRNA
fragments were also highly abundant [46, 52]. It has
been suggested that the depletion of rRNA in oEVs may
have increased the identification of a higher amount of
other types of small ncRNAs (sncRNAs) [52]. However,
many rRNA fragments and fragments of other
non-miRNA ncRNA were in the size range of miRNAs
and thus difficult to remove from miRNA sequences.
Furthermore, pre-miRNAs would be removed by using
size selection of the library products.
In contrast to the protein and mRNA content, the
sncRNA content did not show a clear grouping of stages
based on all sncRNA types or the individual RNA types
analyzed (rRNA, tRNA, snoRNA, miRNA and other
ncRNA). Only for snRNA, a partial grouping of S1-S2 and
S3-S4 samples was observed. Despite no clear separation,
higher differences in sncRNA were also found between S1
and S4 than between the rest of stages analyzed.
Regarding the miRNA content in oEVs, miRNAs rep-
resented with 11–18% of total read counts in the small
RNA data set the most abundant RNA type after the
fragments derived from rRNAs and tRNAs. Their im-
portance as regulators of gene expression is well known
as well as their important role in embryo development
and embryo-maternal communication [53]. To date, dy-
namic changes of miRNA expression have been shown
in both gametes and early embryos in different mamma-
lian species [54–56]. Here, we demonstrated that oEVs
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miRNA content, which may be transferred to both gam-
etes and embryos during the early reproductive events,
is also dynamic and slightly under hormonal regulation.
Burns et al., [26] found that cyclic and pregnant uterine
EVs contain also differential miRNA cargo, identifying
only 1 miRNA specific for pregnant ewes, 27 miRNAs in
cyclic and 53 in common. Our study shared 4 miRNAs
with the Burns et al. [26] data (bta-miR-423 found in
pregnant, bta-miR-429 in cyclic ewes, and bta-miR-148a,
hsa-miR-151 in common).
Among the most abundant miRNAs in oEVs were sev-
eral members of the let-7 family (4 under the top 10),
which appear in exosomes from other cell/tissues and
has been shown to have a conserved role in cell fate de-
termination in the early embryo [57]. Additional miR-
NAs involved in this process are miR-125b [58] and
miR-375 [59] which were under the 30 most abundant
miRNAs in oEVs. Furthermore, increased expression of
miR-148a, the sixth most frequent miRNA in oEVs, has
been shown to improve early development of porcine
cloned embryos by affecting DNA methylation via its
target DNMT1 [60].
Other interesting but less studied sncRNAs such as:
tRNA fragments (representing 5% of sncRNA content)
and Y-RNA (representing the 4% of other sncRNA) were
also identified in oEVs. Transfer RNA fragments have
been associated with a number of regulatory processes,
e.g., during posttesticular sperm maturation and also
regulation of endogenous retroelements active in preim-
plantation embryos [61]. Y-RNA was found in EVs in 3
biotypes RNY1, RNY3, RNY4, being the RNY4 the most
abundant. Y-RNAs function for example at the initiation
step of mammalian chromosomal DNA replication [62]
and RNA quality control via binding to RO60 protein
[63]. Both tRNA fragments and Y RNAs were also iden-
tified in exosomes in human semen by Vojtech et al.,
[64]. These authors suggested they could play immuno-
modulatory functions in the female tract by the delivery
of these small RNA molecules in exosomal semen. Based
on the current knowledge about these sncRNAs, we
hypothesize that tRNAs and Y-RNAs packed in oEVs
could be involved in the immunoregulation of the
oviduct epithelium in preparation for the arrival of
spermatozoa and/or the embryo, contributing to
maternal-sperm/embryo tolerance in the oviduct or
maybe are transferred to the early embryo to assist pro-
cesses involved in genome replication and activation.
Among other sncRNA types identified in oEVs, we
found snRNAs (e.g., RN7SK, spliceosomal RNAs) which
were the only sncRNAs for which a grouping of stages
was found in the PCA analysis based on their expression
levels. These snRNAs have been associated to regulation
of RNA biogenesis and RNA stability [65] as well as im-
mune tolerance [66].
Integration of oviductal EVs molecular content across the
estrous cycle
In attempt to integrate the mRNA and protein data, we
compared all transcripts and proteins identified in bo-
vine oEVs across the estrus cycle, which revealed that al-
most all proteins (96%) were overlapping with the
transcripts identified in oviductal EVs. Only 13 proteins
were not found in all transcripts annotation such as
hemoglobin, serotransferrin, albumin, apolipoprotein,
which may be not contained in EVs from BOEC, but in
EVs from blood or plasma. Besides, other proteins such
as immunoglobulins, histone and other uncharacterized
proteins were not identified among all transcripts, which
may be due to annotation problems. However, here we
found a very high overlap between transcripts and pro-
teins identified in oEVs. Similar findings were obtained
by Ogawa and colleagues [43], who suggested that
protein-coding RNAs and expressed proteins may coex-
ist in secreted EVs.
Biological relevance of oviductal EVs’ content on sperm/
embryo: Implications for the reproductive success
EVs represent ideal natural nanoshuttles for carrying
specific molecules into spermatozoa, the oocyte and/or
the embryo that are not present in the in vitro culture
system. Moreover, the oEVs cargo is a “cocktail” of tran-
scripts, proteins, miRNAs and lipids that can be used as
a strategy to overcome the in vitro culture deficiencies
and promote successful pregnancy. The transfer of pro-
teins from oviduct to sperm/embryos via EVs can have a
direct impact on sperm capacitation and fertilization
ability [11, 24] or supporting early embryo development.
The transfer of mRNA content could lead to the gener-
ation of functional proteins by the embryo and enabling
horizontal transfer of genetic information. The transfer
of miRNA content to sperm/embryos could have a re-
markable impact on regulation of gene expression [12].
Recently, we demonstrated [9] that oEVs supplementa-
tion during in vitro culture improved embryo develop-
ment, quality and survival in vitro. Furthermore,
Lopera-Vásquez et al. [8, 23] demonstrated that oEVs
also improve embryo cryosurvival and alter embryonic
gene expression. Therefore, deciphering the molecular
cargo of oEVs that could be responsible for the increase
in embryo yield as well as in embryo quality and also,
their potential impact on spermatozoa during pre- and
post- fertilization periods seems imperative for us.
Comparative studies regarding the quality of embryos
derived from ART versus in vivo embryos have shown
important differences in the embryonic transcriptome
and proteome profiles. Corcoran et al., [67] showed sup-
pressed expression of genes involved in transcription
and translation (CNOT1, EEF1G, PABPN1, FOXO3A,
DOT1L) and metabolism (GALE, HEBP1) in in vitro
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bovine embryos when compared with in vivo ones.
These transcripts were identified in oEVs in our study.
At the proteomic level, a marked reduced expression of
annexins 1 and 2 in nuclear transfer (NT) derived em-
bryos was observed and associated to the frequent fail-
ures of NT pregnancies, since annexins 1 and 2 are
abundant in the placenta and have functions important
to the maintenance of placentation [68]. Annexin 1 and
2 were among the most abundant proteins in oEVs.
Considering these findings, the immediate question that
arises is whether the supplementation of in vitro culture
media with oEVs could restore the transcript and protein
abundance to the in vivo embryos levels and thus im-
proving the embryo quality. In this regard,
Lopera-Vásquez et al., [8] showed an upregulated ex-
pression of connexin 43 (also known as GJA1) and
GAPDH in in vitro produced embryos after EVs supple-
mentation during culture. Both transcripts are associated
with better quality embryos and increased cryotolerance
[69] and were also identified in the present study. More-
over, GAPDH plays an important role in energy metab-
olism and its mRNA was found as highly abundant in
oEVs (among the 100 most abundant).
On the sperm side, the transcript abundance also var-
ies with differences in sperm motility and is altered after
sperm cryopreservation [70]. Cation channels CATSPER
are very important for sperm fertility. The mRNAs for
the sperm Ca2+ channel auxiliary subunits CATSPERγ
and CATSPERδ were also identifed in oEVs. The
encoded proteins are required for CATSPER channel
function [71]. Cold inducible RNA binding protein
(CIRBP) mRNA was present in oEVs and has been found
as decreased in bovine frozen sperm [72] . The known
and putative functions of many transcripts identified in
oEVs led us to suggest whether the pre-incubation of
sperm in diluents supplemented with EVs, during
fertilization treatments or after cryopreservation/thaw-
ing, could increase the low abundance of specific tran-
scripts in the spermatozoa and improve their
functionality. Sperm can uptake EVs and transfer a spe-
cific protein (PMCA4) with an impact on sperm fertility,
as demonstrated by Al-Dossary et al. [7]. The transfer
of transcripts into sperm could have important impli-
cations in fertility, since some sperm RNAs are trans-
ferred into early embryos and regulate cell signaling
processes or modulate epigenetic events during em-
bryo development [70].
In this regard, EVs-associated miRNAs have been pro-
posed as important players in fertilization and early em-
bryonic development [53]. This is supported by the
finding that many of the most abundant miRNAs identi-
fied in oEVs are known to be involved in the regulation
of early embryo development and epigenetic regulation
of gene expression (see above). With respect to miRNA
expression regulation in oEVs during the estrous cycle,
we focused on miR-449a, which was significantly upreg-
ulated in EVs during S1 compared to the rest of the ana-
lyzed stages, and has been associated to different causes
of infertility in men and women. Dysregulation of
miR-449a and miR-34c have been associated with defect-
ive cilia in the oviduct, inducing alterations in the trans-
port of spermatozoa to meet the oocyte or the transport
of the embryo to the uterus and thus, leading to infertility
[73]. Furthermore, miR-449a has been associated with the
regulation of multiciliogenesis [74]. In addition, a reduc-
tion of miR-34b-3p expression in human spermatozoa has
been found to be directly related to aging [75].
Furthermore, target gene analysis of miR-449a showed
a network of genes associated also to embryo develop-
ment, angiogenesis, response to oxidative stress and
chemotaxis or cell motility, suggesting implications in
successful pregnancy. Moreover, hsa-miR-30d, identified
also in our study and in EVs from human uterine fluid is
taken up by mouse embryos, resulting in modifications
of the embryonic transcriptome and embryo adhesion
[12]. Altogether, this suggests that EVs’ miRNAs act as
modulators of gene expression involved in development
of the early embryo. Indeed, EVs associated RNAs have
been proposed as a carrier of epigenetic information
[76]. In this context, Reilly et al., [13] demonstrated the
selective transfer of miRNA cargo between epididymo-
somes and mouse spermatozoa. The transfer of miRNA
via EVs could be a good strategy to increase the low
number of specific miRNAs in subfertile sperm samples,
modifying the sperm epigenome. Specific miRNAs were
differentially represented in fertile versus subfertile cryo-
preserved bull semen [77] and low versus high motile
bull cryopreserved sperm [78].
At this point, we would like to bring up that it is im-
portant to distinguish between the presence of specific
transcripts, proteins, miRNA or other molecules in oEVs
and their functional activity on the sperm/embryos. Cur-
rently, there is a dearth of knowledge of the actual activ-
ity levels of the transcripts, proteins or miRNAs found
in EVs in the recipient cells, which it is even more unex-
plored in regard to reproductive processes. Further in-
vestigations are required to define precisely which
components of the EVs cargo are most important and
how the fate of spermatozoa and early embryos may be
dictated by the EVs molecular cargo. Our study repre-
sents an essential starting point for: 1) understanding
the potential role of oEVs in sperm functionality,
fertilization and embryo development; 2) the design of
more in-depth investigations about the functional activ-
ity of crucial molecules identified in oEVs on early
sperm/embryo-maternal interactions and their potential
use to improve the efficiency of different ART; 3) the de-
velopment of synthetic EVs for the delivery of specific
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molecules into spermatozoa, embryos or the maternal
tract, under different conditions of infertility.
Conclusions
This is the first comprehensive attempt to reveal the
mRNA, protein and small ncRNA content of oEVs. This
study shows a complex and dynamic molecular signature
of oEVs under the hormonal control of the estrous cycle,
with marked differences between post-ovulatory and
pre-ovulatory stages. Our findings reveal specific mo-
lecular cargo in oEVs with potential roles in sperm func-
tionality, early embryonic gene expression regulation
and development, and gamete/embryo-oviductal interac-
tions. Our study provides a starting point for future
more in-depth investigations of the role of EVs in early
sperm/embryo-maternal interactions and their potential
use to improve the efficiency of different reproductive
biotechnologies.
Methods
Collection of samples
EVs samples were collected from oviducts under differ-
ent hormonal regulation along the estrous cycle. Pairs of
oviducts with their attached ovaries were collected from
cyclic (corpus lutea (CL) present), nonpregnant cows at
a local abattoir (Sablé sur Sarthe, France) and trans-
ported to the laboratory, with the permission of the dir-
ection of the slaughterhouse and the agreement of local
sanitary services. Then, oviducts were classified into one
of the 4 stages of the estrous cycle according to the
morphology of the CL and follicle populations as previ-
ously described by Ireland et al., [79] and used also by
Lamy and collaborators [16] recently. Briefly, the stage
of the estrous cycle classified as stage 1 (S1): showed re-
cently ovulated follicle (d 1 to 4 of estrous cycle); stage 2
(S2): early luteal development with medium or large fol-
licles or both present (d 5 to 11); stage 3 (S3): fully func-
tional CL yellow or orange in color (d 11 to 17); or stage
4 (S4): regressing CL with little vasculature and a large
preovulatory follicle present (d 18 to 20).
Isolation of oviductal EVs
Oviducts were dissected free from surrounding tissues
and flushed with 500 μl of sterile PBS (Sigma
P4417-TAB, Lyon, France) to recover the oviductal fluid.
EVs were isolated by ultracentrifugation [9, 80]. First,
flushing samples were centrifuged at 300 g for 15 min,
followed by 2000 g for 15 min, and then at 12000 g for
15 min to remove cells, blood, and cell debris and cen-
trifuged twice at 100,000 g for 90 min (BECKMAN
L8-M; SW41T1 rotor) to pellet exosomes. The pellets
were resuspended in 50 μL of PBS and stored at − 80 °C
for further analysis. A total of 60 animals were used in
different 5 replicates for the 4 stages of the estrous cycle
analyzed. Oviductal flushings from 3 animals were
pooled for each replicate. Same EVs samples were used
for transmission electron microscopy observations and
proteomic and transcriptomic analysis.
Characterization and quantification of oviductal EVs
across the bovine estrus cycle
Transmission electron microscopy (TEM)
EVs suspensions were diluted in PBS to attain a protein
concentration of 0.6 μg per μL and evaluated for size
distribution by TEM. Three microliters of the sample
were placed on the formvar carbon-coated grid for
5 min and washed with distilled water (three times). For
negative contrast the samples were incubated in 2%
water solution of uranyl acetate (30 s three times, 5 μl)
and left to dry in the small drop (near 1 μl) of last solu-
tion. The micrographs were obtained using TEM HITA-
CHI HT 7700 Elexience at 80 kV (with a charge-coupled
device camera AMT) and JEM 1011 (JEOL, Japan)
equipped with a Gatan digital camera driven by Digital
Micrograph software (Gatan, Pleasanton, USA) at
100 kV. The processing of the photos and vesicle size
calculation were carried out by ImageJ software. For
TEM analysis, 3 different replicates of EVs samples at 4
different stages of the estrous cycle were analyzed.
Nanoparticle tracking analysis (NTA)
EVs suspensions were also evaluated for size and con-
centration on Nanosight equipment (Malvern, Inc.)
using the software NTA 3.1 Build 3.1.45. The initial dilu-
tion factor used for the reading was 1:100 with PBS dilu-
ent. EVs analysis were performed with the sCMOS
camera at the Camera Level of 13, in 5 videos of 30 s
each and temperature controlled of 37 °C. For the ana-
lysis performed by the software Detect Threshold was 3
and Blur Size was Auto. The NTA analysis was per-
formed in a different batch of samples (3 replicates/4
stages).
RNA-sequencing and analysis
Messenger RNA (mRNA) library preparation, sequencing
and data analysis
RNA was isolated from a total of 20 EVs samples (5 rep-
licates, 4 stages) using RNeasy Micro kit (QIAGEN) ac-
cording to the manufacturer’s instructions. RNA quality
and concentration was evaluated by Agilent 2100 Biona-
lyzer (Agilent Technologies, Santa Clara, CA.) and
NanoDrop (ThermoFisher). Poly(A) RNA was isolated
starting from of 450 ng of total RNA by the use of
NEXTflex™ Poly(A) beads. Poly(A) RNA was used for
the preparation of mRNA libraries with the NEXTflex™
Rapid Directional qRNA-Seq Kit (Bioo Scientific). Li-
brary preparation followed the manufacturer’s
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instructions. Sequencing of the libraries was conducted
on an Illumina HiSeq 2500 instrument at the Functional
Genomics Center Zurich (FGCZ). Pooled barcoded li-
braries were run on two lanes of a single flow cell gener-
ating between 4 and 11 million single-end reads
(125 bp) per sample.
The obtained sequence reads (Fastq files) were an-
alyzed with an established analysis pipeline inte-
grated in a local Galaxy installation [81] at the
Animal Physiology group, ETH, Zurich. First, the se-
quence reads were processed with Trim Galore! to
remove low quality from the 3′ end, adapter se-
quences, and sequences below a minimal length of
50 nt after the trimming steps. Subsequently, re-
moval of PCR duplicates was done using FastUniq
tool. Then, the tool Trimmomatic was used to cut 9
bases from the start of the read (HEADCROP) as
these bases are derived from the molecular code
contained in the adapter sequence. To control the
performance of the processing steps, all Fastq files
were quality checked after each processing step with
FastQC (v0.11.2) and MultiQC. Reads were mapped
with HISAT2 (v1.4.0) to the bovine genome sequence
assembly (bosTau8, UMD_3.1.1). Based on the most
current bovine GFF3 annotation file from NCBI and
the mapping information for the reads (BAM files), a
read count table for all annotated bovine mRNA se-
quences was generated using QuasR Qcount. This
count table was filtered to remove sequences with
negligible read counts by using counts per million
(CPM) per sample filtering tool [82] (https://
www.bioconductor.org/packages/devel/bioc/vignettes/
edgeR/inst/doc/edgeRUsersGuide.pdf ). The mean li-
brary size and potential CPM cutoff (Counttable sta-
tistics, in-house tool) was calculated and the cutoff
set to 4.21 CPM (corresponding to an average of 20
reads per library) for at least 3 out of 20 libraries.
This count table was the basis for the subsequent
statistical analysis.
From a total of 20 samples in mRNA seq-dataset, 2
outliers (S1_R5; S4_R3) were removed because the low
integrity of mRNA (RIN < 5) and other 2 outliers
(S2_R4, S3:_R1) were removed because of the presence
of high amount of universal adaptor after clipping. Then,
the cutoff was set to 3.93 CPM and for at least 2 out of
16 libraries.
The analysis of differential mRNA expression was per-
formed using BioConductor package EdgeR [83]. Data
normalization was performed on library size (TMM
normalization) [84] and with GLM robust (estima-
teGLMRobustDisp) [85] function. For comparison of the
experimental groups, the following contrasts were set:
S2 versus S1; S3 vs. S1 and S4 vs. S1. An adjusted
p-value (false discovery rate, FDR) of 0.1% was used as
threshold for significance of differentially abundant
mRNA sequences.
RNA-Seq data have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO
SuperSeries GSE110444 (mRNA data: GSE110399 and
ncRNA data: GSE110443).
Access SuperSeries RNA data: https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE110444
Access Subseries mRNA data: https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE110399
Small RNA library preparation, sequencing and data
analysis
RNA was isolated from the same 20 EVs samples (5 rep-
licates, 4 stages) but using miRNeasy Mini kit (QIA-
GEN) according to the manufacturer’s instructions. A
total of 444 ng RNA was used for the preparation of
each small RNA library using NEXTflex™ Small
RNA-Seq Kit v3 (Bioo Scientific). Sequencing of the
small RNA libraries was conducted on an Illumina
HiSeq 2500 instrument at the FGCZ.
The small RNA sequence data analysis was processed
using the same Galaxy pipeline at ETH, Zurich as men-
tioned above. First, adapter sequences were removed (3′
adapter sequence (TGGAATTCTCGGGTGCCAAGG)
with the tool “clip adapter” (Version 1.0.1 FASTX-toolkit
by Assaf Gordon). PCR duplicates were removed using
the four random nucleotides on each side of the RNA
fragment introduced with the adapters as molecular
codes by running the tool “Collapse”. Then, the four
random bases were removed from each side and “Col-
lapse” was again used to obtain the unique sequences
and the corresponding read counts corrected for PCR
duplicates. Subsequently, a count table for all obtained
unique sequences corresponding to a small ncRNA was
generated using a series of further standard Galaxy tools
as well as converting tools from the ToolShed (https://
toolshed.g2.bx.psu.edu/). The resulting table contained
the unique sequences and the number of reads per sam-
ple. This count table was filtered to remove sequences
with negligible read counts, comprising sequencing er-
rors or sequences with very low evidence for potential
expression by using CPM per sample filtering tool [82]
(https://www.bioconductor.org/packages/devel/bioc/vi-
gnettes/edgeR/inst/doc/edgeRUsersGuide.pdf.) The
minimum library size and potential CPM cutoff (Count-
table statistics, in-house tool) was calculated and the
cutoff set to 8.41 CPM (corresponding to an average of
20 reads per library) for at least 3 out of 20 libraries.
This count table was the basis for the subsequent statis-
tical analysis and to annotate the sequences.
From a total of 20 samples in small RNA seq-dataset, 2
outliers (S2_R1; S4_R5) were removed because of the low
integrity of mRNA (RIN) and the presence of high amount
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of universal adaptor after clipping). Then, the cutoff was set
to 8.41 CPM and for at least 3 out of 18 libraries.
Small RNA sequences were annotated based on
BLAST (Basic Local Alignment Search Tool) searches
against a number of sequence databases. The collection
of BLAST databases contained sequences from miRBase
(bovine, human, and porcine precursor and canonical
mature miRNAs), transcript sequences from NCBI and
Ensembl, including non-coding RNAs, as well as tRNA
and piRNA cluster sequences retrieved from the NCBI
Bos taurus UMD 3.1.1 GFF3 file and http://www.smallr-
nagroup.uni-mainz.de/piRNAclusterDB.html, Rosenk-
ranz D. piRNA cluster database: a web resource for
piRNA producing loci. Nucleic Acids Research 2016
44(D1):D223-D230, respectively. The current miRBase
release 21 contains 808 precursors and 793 mature bo-
vine miRNAs.
The analysis of differential abundance of sequences
was performed using BioConductor package EdgeR [83].
To normalize the read count data, the dataset was proc-
essed with TMM normalization [84] and GLM robust
(estimateGLMRobustDisp) [85]. For comparison of the
experimental groups, the following contrasts were set:
S2 versus S1; S3 vs. S1, and S4 vs. S1. An adjusted
p-value (false discovery rate, FDR) of 5% was used as
threshold for significance of differentially expressed se-
quences (separately for ncRNA, rRNA, snoRNA, snRNA,
tRNA, and miRNA sequences). Expression values
(counts per million, cpm) of identified differentially
expressed sequences (DES) were further processed in R
to perform hierarchical cluster analysis by samples and
DES [Gregory R. Warnes et al., https://CRAN.R-projec-
t.org/package=gplots 2016].
Small RNA-Seq data have been deposited in NCBI’s
Gene Expression Omnibus and are accessible through
GEO SuperSeries GSE110444 (mRNA data: GSE110399
and ncRNA data: GSE110443).
Access SuperSeries RNA data: https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE110444
Access Subseries ncRNA data: https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE110443
Proteomic analysis
EVs samples were analyzed by SDS-PAGE combined
with nanoLiquid Chromatography coupled to high reso-
lution tandem mass spectrometry (nanoLC-MS/MS)
with spectral counting quantitative method.
Sample preparation for MS analysis
Protein concentrations in the EVs samples were deter-
mined using the Uptima BC Assay kit (Interchim, Mon-
tluçon, France) according to manufacturer’s instructions
and using bovine serum albumin as a standard. EVs
samples from replicate 1–4 from same stage were pooled
(10 μg EVs preparation/replicate) and 4 pools corre-
sponding to S1, S2, S3, and S4 samples were analyzed by
spectrometry analysis. A total of 30 μg of total protein/
stage of EVs pooled samples were used. EVs samples
were suspended in Laemmli buffer [86], followed by vor-
texing and incubation in a water bath at 95C° 5 min.
Then, EVs samples were included in 10% SDS-PAGE
(8.3 cm × 7.3 cm × 1.5 mm gels, 50 V, 30 min) without
fractionation. Thus, samples were concentrated in a sin-
gle narrow band. The resulting protein bands from 4
stages (1 band/stage) were stained with Coomassie blue
(G-250). Densitometric quantification of Coomassie
blue-stained protein bands was performed by transmis-
sion acquisition with an ImageScanner (GE Healthcare,
Orsay, France) and analyzed with TotalLab (Nonlinear
Dynamics Limited, Newcastle, UK) to check for the
equivalent amount of protein among samples. Then,
each lane was cut horizontally in 3 bands for a quantita-
tive proteomic analysis. Gel slices from the four pooled
samples were in-gel digested by trypsin and peptides
were analyzed by Nano LC-MS/MS as previously de-
scribed [9].
Nano LC-MS/MS analysis
Peptide mixtures were analyzed by nanoflow liquid
chromatography-tandem mass spectrometry (nanoLC–
MS/MS). All experiments were performed on a LTQ
Orbitrap Velos mass spectrometer (Thermo Fisher Sci-
entific, Bremen, Germany) coupled to an Ultimate® 3000
RSLC Ultra High Pressure Liquid Chromatographer
(Dionex, Amsterdam, The Netherlands) controlled by
Chromeleon Software (version 6.8 SR11; Dionex,
Amsterdam, The Netherlands). Six microliters of each
sample were loaded on trap column for desalting and
separated using nano-column as previously described by
Labas et al. [87]. Three nanoLC-MS/MS analyses were
performed for each in vivo and in vitro EVs preparations.
Data were acquired using Xcalibur software (version 2.1;
Thermo Fisher Scientific, San Jose, CA). The instrument
was operated in positive data-dependent mode. Reso-
lution in the Orbitrap was set to R = 60,000. In the scan
range of m/z 300–1800, the 20 most intense peptide ions
with charge states ≥2 were sequentially isolated (isola-
tion width, 2 m/z; 1 microscan) and fragmented using
Collision Induced Dissociation (CID). The ion selection
threshold was 500 counts for MS/MS, and the maximum
allowed ion accumulation times were 200 ms for full scans
and 50 ms for CID-MS/MS in the LTQ. Target ion quan-
tity for FT full MS was 1e6 and for MS/MS it was 1e4.
The resulting fragment ions were scanned at the “normal
scan rate” with q = 0.25 activation and activation time of
10 ms. Dynamic exclusion was active during 30 s with a
repeat count of 1. The lock mass was enabled for accurate
mass measurements. Polydimethylcyclosiloxane (m/z,
Almiñana et al. BMC Genomics  (2018) 19:622 Page 22 of 27
445.1200025, (Si(CH3)2O)6) ions were used for internal re-
calibration of the mass spectra.
Data processing and statistical analysis
MS/MS ion searches were performed using Mascot
search engine v 2.2 (Matrix Science, London, UK) via
Proteome Discoverer 2.1 software (ThermoFisher Scien-
tific, Bremen, Germany) against a locally maintained
copy of NCBInr (571,109 Mammalia entries, download
January 2016). The parameters used for database
searches included trypsin as a protease with two missed
cleavages allowed, and carbamidomethylcysteine, oxida-
tion of methionine and N-terminal protein acetylation as
variable modifications and peptide charge 2 and 3+. The
tolerance of the ions was set at 5 ppm for parent and
0.8 Da for fragment ion matches. Mascot results ob-
tained from the target and decoy databases searches
were subjected to Scaffold 4 software (v 4.4.7, Proteome
Software, Portland, USA) for validation. Peptide identifi-
cations were accepted if they could be established at
over 95.0% probability as specified by the Peptide
Prophet algorithm [88]. A false discovery rate was calcu-
lated as < 1% at the peptide or protein level.
For comparative analysis, we employed Scaffold Q+
software (version 4.4, Proteome Software, Portland,
USA) for spectral counting label-free quantitative
method with “Weighed Spectra” option on protein clus-
ters. A t-test was performed to characterize changes be-
tween in vivo and in vitro EVs preparations. Differences
were considered statistically significant for t-tests (phase
of cycle comparison) at p-value< 0.05. Limits of an aver-
age normalized weighted spectra (NWS) of ≥5 and fold
change/ratio of ≥2 were included to increase validity of
any comparisons made.
MS data have been deposited to the ProteomeXchange
Consortium via the PRIDE [89] partner repository with
the dataset identifier PXD008851 and https://doi.org/
10.6019/PXD008851.
Data mining and bioinformatics analysis
Gene symbols and Entrez Gene IDs (bovine and putative
human orthologs) were mapped for all transcripts, small
RNA and protein identifications and analyzed using bio-
informatics custom tools integrated in a local Galaxy [81]
installation. Custom database tools (NCBI annotation
mapper, Mammalian Ortholog and Annotation database,
MOADb; Bick J, ETH Zurich, unpublished results 2017)
were used to assign known or putative human ortholo-
gous genes. Human gene identifiers or symbols were used
for subsequent functional annotation. Functional analysis
of transcripts and proteins contained in EVs was per-
formed using DAVID 6.8 Functional Annotation (https://
david.ncifcrf.gov) [90, 91]. DIANA-miRPath v3.0 and Tar-
Base v.7 was used for gene target analysis from candidate
miRNA and further functional analysis of target genes and
clustering. TarBase v.7 allowed us to select only validated
target genes from selected miRNA for pathways analysis.
Comparative enrichment clustering and network was per-
formed using ToppCluster tool [92] (https://toppclus-
ter.cchmc.org) for differentially abundant transcripts (DT)
and proteins (DP) across the bovine estrous cycle.
Protein and miRNA validation
Western blotting Proteins were separated by
SDS-PAGE and transferred onto nitrocellulose mem-
branes (GE Healthcare Life Sciences Whatman™). The
membranes were washed in distilled water and blocked
with Tris-buffered saline (TBS) containing Tween 20
(0.5% (w/v)), and supplemented with lyophilized low-fat
milk (5% w/v) for 1 h at room temperature. The mem-
branes were incubated with primary antibodies diluted
in TBS-Tween containing low-fat milk (1% w/v) for 2 h
at 37 °C with gently shaking. The primary antibodies
used were: anti-heat shock protein 70 (HSP70; Stressgen,
SPA-810); anti-annexin I (ANXA1, Santa Cruz Biotech-
nologies, sc11387); anti-Cluster of Differentiation 109
(CD109, Santa Cruz Biotechnology, sc98793); anti-heat
shock protein A8 (HSPA8; bioss.com, bs-5117R);
anti-Myosin heavy chain 9 (MYH9 (H40), Santa Cruz
Biotechnology, sc-98,978). After primary antibodies in-
cubation, the membranes were washed with TBS with
0.5% Tween 20 and incubated overnight at 4 °C under
agitation with secondary antibodies. The secondary anti-
bodies used were: horseradish peroxidase (HRP)-anti--
mouse (Sigma A4416) or anti-rabbit (Sigma A6154).
Blots were developed using a mixture of two chemilu-
minescence substrates developing kit (GE Healthcare
AmershamTH ECL SelectTH Western blotting detection
Reagent RPN2235 and Supersignal West Pico #34087
Chemiluminescent Substrate Thermo Scientific).
Real-time PCR expression analysis of miRNAs Com-
parative expression of bta-miR-449a along the bovine es-
trus cycle was analyzed by qPCR, since its dysregulation
has been associated with defective cilia in the oviduct
and infertility. Using a new batch of EVs isolated from
oviducts classified in the four stages of the estrous cycle
(n = 12), total RNA, including microRNAs, was purified
from isolated oviduct EVs using the miRNeasy Mini Kit
(QIAGEN), according to the manufacturer’s instructions.
Mature and precursors microRNAs, mRNAs and
non-coding RNAs were transformed into cDNA by re-
verse transcription using the miScript II RT Kit (QIA-
GEN), according to the manufacturer’s instructions. A
10 μL reaction was performed for each sample, with
200 ng of total RNA. Reverse transcription was per-
formed in a thermocycler (Life Technology), incubated
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at 37 °C for 60 min, followed by 95 °C for 5 min to in-
activate a reverse transcriptase. Samples were stored at
− 20 °C.
The expressions of bta-miR-449a was analyzed using the
miScript SYBR® Green PCR Kit (QIAGEN) according to
the manufacturer’s instructions. Primers sequences (5′ -
3′)) used for qPCR: for bta-miR-449a (TGGCAGTGT
ATTGTTAGCTGGT) and 3 endogenous (RNT43
snoRNA: CTTATTGACGGGCGGACAGAAAC; Hm /
Ms. / Rt T1 snRNA: CGACTGCATAATTTGTGGT
AGTGG and bta-miR-99b: CACCCGTAGAACCGACCTT
GCG. The reactions were performed in duplicate in total
volume of 6 μl, containing 2X QuantiTect SYBR Green
PCR Master Mix, 10X miScript Universal Primer,
10X miScript Primer Assay, RNase free-water and
0.4 ng of cDNA. The RT-PCR was performed on the
QuantStudio 6 Flex (Life Technology) equipment.
Temperature and time conditions were 95 °C for
15 min for activation of HotStarTaq DNA Polymer-
ase and 45 cycles at 94 °C for 15 s for denaturation,
55 °C for 30 s for annealing and 70 °C for 30 s for
extension. Finally, the melting curve was performed.
MicroRNAs were considered present at Ct values
below 35 cycles and the amplification product was
confirmed from the melting curve analysis.
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